Prof. Peter York
Peter has over 30 years experience as a pharmaceutical scientist and entrepreneur and was founder of Bradford Particle Design Ltd, a spinout venture from the University of Bradford. The company, based on research and patents in particle formation by supercritical fluids, was acquired by Inhale Therapeutics (now Nektar Therapeutics) in 2001. In addition to leading Lena Nanoceutics, Peter continues his research activities as Professor of Physical Pharmaceutics at the University of Bradford. He has consulted widely throughout the world, published over 300 scientific articles, holds numerous patents, and has received several research awards.
Paul has more than 20 years experience working in the chemical and pharmaceutical industries in manufacturing, research, marketing, consultancy and senior executive roles. In addition to his role at Lena, Paul is Director of the Institute of Pharmaceutical Innovation and continues to provide lifecycle management consultancy to the pharmaceutical industry, as well as mentoring of entrepreneurs. Paul is a member of the UK-China Joint Economic Trade Commission Healthcare Working Group, and is a non-executive Director of Medilink (Yorkshire and Humber).
Dr Brian Sulaiman
Founder of partner company Dena Systems, Brian brings a wealth of expertise in engineering technology to the company. Brain has a doctorate in Engineering and many years industrial experience. He founded the Dena group of companies in the mid-90s which has commericialised Brian’s patented engineering technologies and now operates across many regions of the world, including Europe and Asia.